Andrew Bayliffe

Andrew Bayliffe is the founder of Marengo Therapeutics. Marengo Therapeutics has raised $80M in total funding. Latest round: Series B. Based in Cambridge, MA.

About Andrew Bayliffe

Andrew Bayliffe is the Chief Scientific Officer at Marengo Therapeutics, a clinical-stage biotechnology company. Marengo Therapeutics develops precision immunotherapies using its selective T-cell activation repertoire (STAR) platform to engineer novel TCR-targeting antibodies.

Andrew Bayliffe at a glance

More founders in Cambridge, MA (44)

Browse related founder lists (4)

Full founder directory · Investor directory · Company funding database · Fundraising library